It is generally agreed that, on average, 40% to 60% of the defects generated by a surface mount production line can ...
Experience the power of CHIMERA, the modular biofabrication platform from Ourobionics that sets a new standard in regenerative medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback